THE ROLE OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS IN THE DEVELOPMENT OF METABOLIC DISORDERS
Keywords:
mitochondrial dysfunction, oxidative stress, reactive oxygen species, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, MASLD.Abstract
Mitochondria play a central role in cellular energy metabolism, fatty-acid oxidation, redox regulation, calcium homeostasis, apoptosis, and metabolic adaptation. Disturbances in mitochondrial function are increasingly recognized as important contributors to obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and metabolic dysfunction-associated steatotic liver disease. One of the major consequences of mitochondrial dysfunction is excessive production of reactive oxygen species, which can damage lipids, proteins, mitochondrial DNA, and cellular membranes and can also interfere with insulin signaling and inflammatory regulation. The aim of this study was to analyze the biochemical mechanisms linking mitochondrial dysfunction and oxidative stress with the development of metabolic disorders. A qualitative literature-based review was conducted using contemporary studies on oxidative phosphorylation, reactive oxygen species, insulin resistance, mitochondrial dynamics, mitophagy, β-cell dysfunction, hepatic lipid metabolism, and metabolic inflammation. The analysis indicates that chronic nutrient excess increases mitochondrial substrate pressure and promotes electron leakage, oxidative stress, impaired mitochondrial quality control, and metabolic inflexibility. These changes contribute to ectopic lipid accumulation, insulin resistance, pancreatic β-cell dysfunction, hepatic steatosis, and chronic low-grade inflammation. The available evidence suggests that mitochondrial dysfunction and oxidative stress form a self-amplifying pathogenic cycle. Effective prevention and treatment therefore require restoration of metabolic and mitochondrial homeostasis rather than simple nonspecific antioxidant supplementation.
References
1. Zong Y, Li H, Liao P, et al. Mitochondrial dysfunction: Mechanisms and advances in therapy. Signal Transduction and Targeted Therapy. 2024;9:124.
2. Sies H, Jones DP. Reactive oxygen species as pleiotropic physiological signalling agents. Nature Reviews Molecular Cell Biology. 2020;21:363–383.
3. Murphy MP. How mitochondria produce reactive oxygen species. Biochemical Journal. 2009;417:1–13.
4. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux. Journal of Clinical Investigation. 2016;126:12–22.
5. Dai W, Jiang L. The complex interplay between imbalanced mitochondrial dynamics and metabolic disorders in type 2 diabetes. International Journal of Molecular Sciences. 2023;24.
6. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 5th ed. Oxford University Press; 2015.
7. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384–387.
8. Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiological Reviews. 2018;98:2133–2223.
9. Fazakerley DJ, Minard AY, Krycer JR, et al. Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation. Journal of Biological Chemistry. 2018;293:7315–7328.
10. Xia W, et al. Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. Nature Metabolism. 2024.
11. Prentki M, Nolan CJ. Islet β-cell failure in type 2 diabetes. Journal of Clinical Investigation. 2006;116:1802–1812.
12. Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease. Annals of Hepatology. 2025.
13. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biology and Medicine. 2012;52:59–69.
14. Tang S, Hao D, Ma W, et al. Dysfunctional mitochondria clearance in situ: Mitophagy in obesity and diabetes-associated cardiometabolic diseases. Diabetes & Metabolism Journal. 2024;48(4):503–517.
15. Tang S, Geng Y, Lin Q. The role of mitophagy in metabolic diseases and its exercise intervention. Frontiers in Physiology. 2024;15:1339128.
